Sequence-defined multifunctional polyethers via liquid-phase synthesis with molecular sieving

Abstract

Synthetic chemists have devoted tremendous effort towards the production of precision synthetic polymers with defined sequences and specific functions. However, the creation of a general technology that enables precise control over monomer sequence, with efficient isolation of the target polymers, is highly challenging. Here, we report a robust strategy for the production of sequence-defined synthetic polymers through a combination of liquid-phase synthesis and selective molecular sieving. The polymer is assembled in solution with real-time monitoring to ensure couplings proceed to completion, on a three-armed star-shaped macromolecule to maximize efficiency during the molecular sieving process. This approach is applied to the construction of sequence-defined polyethers, with side-arms at precisely defined locations that can undergo site-selective modification after polymerization. Using this versatile strategy, we have introduced structural and functional diversity into sequence-defined polyethers, unlocking their potential for real-life applications in nanotechnology, healthcare and information storage.

Dong, R., Liu, R., Gaffney, P.R.J. et al. Nature Chem 11,136–145 (2019)

https://doi.org/10.1038/s41557-018-0169-6

New R&D Facilities

Exactmer is excited to announce the opening of its new R&D facilities and office space in the Londoneast-UK Business and Technical Park. The move from Imperial College London to the new premises marks the beginning of an exciting growing phase for the company. The facilities in Londoneast will allow Exactmer to accommodate its fast-growing team, scale up its manufacturing capabilities and establish new and successful partnerships with its clients and industrial collaborators.

Biologics Series

Exactmer is delighted to attend the Oxford’s Global Biologics Series conference, held in London from 26th to 28th August 2020. This conference brings together experts from global pharmaceutical organisations, academia and biotech companies, working on peptides, oligonucleotides, proteins and therapeutic development. Exactmer’s CEO, Prof Andrew Livingston, will deliver a presentation on our Nanostar Sieving technology and its applications in oligonucleotides manufacturing.